<DOC>
	<DOC>NCT00034801</DOC>
	<brief_summary>This is a research study comparing the safety and efficacy of two active study medications</brief_summary>
	<brief_title>Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Ziprasidone</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Male or female subjects 1860 years of age Female subjects of childbearing potential must be using a medically accepted means of contraception Each subject must have a level of understanding sufficient to perform all tests and examinations required by the protocol Subjects must be considered reliable Treatment with a drug within the last 30 days that has not received regulatory approval at the time of study entry Female subjects who are either pregnant or nursing Uncorrected hypothyroidism or hyperthyroidism Narrowangle glaucoma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2006</verification_date>
	<keyword>Depression</keyword>
	<keyword>Comorbid Depression</keyword>
	<keyword>Schizophrenia</keyword>
	<keyword>Schizoaffective Disorder</keyword>
</DOC>